Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications
PaperCitations, authors & open-access status
A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1 citations, 2026 year and gold oa status.
1
Citations
2026
Year
gold
OA Status